News

Psoriasis

Protagonist Therapeutics Gets $25 Million Milestone Payment From Janssen for Psoriasis Trial Progress

Edward Kim | Equities.com |

The deal is designed to extend Janssen's blockbuster Stelara franchise.


Sponsored Financial Content

Market Movers